Population pharmacokinetics and Bayesian dose adjustment to advance TDM of anti-TB drugs
MGG Sturkenboom, AG Märtson, EM Svensson… - Clinical …, 2021 - Springer
Tuberculosis (TB) is still the number one cause of death due to an infectious disease.
Pharmacokinetics and pharmacodynamics of anti-TB drugs are key in the optimization of TB …
Pharmacokinetics and pharmacodynamics of anti-TB drugs are key in the optimization of TB …
Population Pharmacokinetics and Dose Evaluation of Cycloserine among Patients with Multidrug-Resistant Tuberculosis under Standardized Treatment Regimens
Y Zhu, L Zhu, L Davies Forsman, J Paues… - Antimicrobial Agents …, 2023 - Am Soc Microbiol
Although cycloserine is a recommended drug for the treatment of multidrug-resistant
tuberculosis (MDR-TB) according to World Health Organization (WHO), few studies have …
tuberculosis (MDR-TB) according to World Health Organization (WHO), few studies have …
Population pharmacokinetics of cycloserine and pharmacokinetic/pharmacodynamic target attainment in multidrug-resistant tuberculosis patients dosed with …
MT Chirehwa, R Court, M de Kock… - Antimicrobial Agents …, 2020 - Am Soc Microbiol
Cycloserine is a WHO group B drug for the treatment of multidrug-resistant tuberculosis (TB).
Pharmacokinetic/pharmacodynamic data for cycloserine when dosed as terizidone are …
Pharmacokinetic/pharmacodynamic data for cycloserine when dosed as terizidone are …
Assessing potential drug-drug interactions between clofazimine and other frequently used agents to treat drug-resistant tuberculosis
Clofazimine is included in drug regimens to treat rifampicin/drug-resistant tuberculosis (DR-
TB), but there is little information about its interaction with other drugs in DR-TB regimens …
TB), but there is little information about its interaction with other drugs in DR-TB regimens …
[PDF][PDF] Court R, de Kock M, Wiesner L, de Vries N, Harding J, Gumbo T, Maartens G, Warren R, Denti P, McIlleron H. 2020. Population pharmacokinetics of cycloserine …
MT Chirehwa - Antimicrob Agents Chemother - academia.edu
Cycloserine is a WHO group B drug for the treatment of multidrugresistant tuberculosis (TB).
Pharmacokinetic/pharmacodynamic data for cycloserine when dosed as terizidone are …
Pharmacokinetic/pharmacodynamic data for cycloserine when dosed as terizidone are …
Atomic and molecular properties of nonclassical bioisosteric replacements of the carboxylic acid group
AA Arabi - Future Medicinal Chemistry, 2020 - Taylor & Francis
Aim: Drug design is fraught with challenges as small differences in the structure of a drug
molecule can significantly affect its biological activity. Bioisosteres are interchangeably used …
molecule can significantly affect its biological activity. Bioisosteres are interchangeably used …
Amount of cycloserine emanating from terizidone metabolism and relationship with hepatic function in patients with drug-resistant tuberculosis
M Mulubwa, P Mugabo - Drugs in R&D, 2019 - Springer
Background and objectives The dosing of cycloserine and terizidone is the same, as both
drugs are considered equivalent or used interchangeably. Nevertheless, it is not certain from …
drugs are considered equivalent or used interchangeably. Nevertheless, it is not certain from …
[HTML][HTML] Influence of anti-tuberculosis drugs plus cycloserine on sputum negative conversion rate, adverse reactions and inflammatory factors in multi-drug resistant …
W Gao, N Yang, X Mei, X Zhu, W Hu… - American Journal of …, 2021 - ncbi.nlm.nih.gov
Objective: The aim of this investigation was to determine the influence of anti-tuberculosis
(anti-TB) drugs plus cycloserine (CS) on the sputum negative conversion rate, adverse …
(anti-TB) drugs plus cycloserine (CS) on the sputum negative conversion rate, adverse …
Natural Product-Based Treatment for Tuberculosis
G Prusty, SR Panda, RR Behera, SL Bhushan… - Natural Products for …, 2024 - Springer
Tuberculosis (TB), caused by the bacterial organism Mycobacterium tuberculosis, has
remained a persistent global health challenge, profoundly impacted millions of lives and …
remained a persistent global health challenge, profoundly impacted millions of lives and …
[PDF][PDF] 基于前馈控制康复护理对肺结核患者临床效果, 肺功能及依从性的影响
耿果红 - 中华养生保健, 2022 - zhysbjzz.com
目的分析基于前馈控制康复护理对肺结核患者临床效果, 肺功能及依从性的影响.
方法前瞻性分析选择2020 年5 月~ 2021 年5 月菏泽市传染病医院收治的78 例肺结核住院患者 …
方法前瞻性分析选择2020 年5 月~ 2021 年5 月菏泽市传染病医院收治的78 例肺结核住院患者 …